Evaluation of the effect of long term feeding of novel glucomannan containing gruel on glucose and lipid metabolism.

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs031200221

Enrollment

Registered

2020-11-30

Start date

2021-01-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy subjects or diabetes mellitus controlled under HbA1c 7.0% (NGSP) Hyperglycemia

Interventions

taking glucomannan containin or placebo gruel for 2 weeks taking glucomannan containin or placebo gruel for 2 weeks (cross over)

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: healthy subjects or diabetes patients with HbA1c <7%

Exclusion criteria

Exclusion criteria: diabetes patients with HbA1c >= 7% diabetes patients under drug treatment patients with severe constipation

Design outcomes

Primary

Measure	Time frame
decrease of glucose and insulin values	—

Secondary

Measure	Time frame
decrease of HbA1c, glycoalbumin, triglycerides and LDL-cholesterol, increase of 1,5-AG and HDL-cholesterol	—

Contacts

Public ContactAkihiro Yoshida

Gunma University Hospital

ayossie10@gunma-u.ac.jp+81-27-220-8576

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026